Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G5WV
|
||||
Former ID |
DIB015477
|
||||
Drug Name |
KTE-C19 CAR
|
||||
Indication | Diffuse large B-cell lymphoma [ICD9: 200; ICD10:C83.3] | Phase 1/2 | [549522] | ||
Company |
Kite pharma santa monica; national cancer institute
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD19 | Target Info | Inhibitor | [549913] | |
NetPath Pathway | IL-7 Signaling Pathway | ||||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.